Overview

Genetic Variation in TRAF3IP2 (rs13190932)

Status:
RECRUITING
Trial end date:
2026-06-10
Target enrollment:
Participant gender:
Summary
Psoriasis is an immune-mediated inflammatory disease that is highly prevalent worldwide, affecting approximately 2-3% of the world population. It is characterized by red, scaly plaques that can appear on various parts of the body, causing significant physical and psychological burden to affected individuals. The Pathogenesis of PsA involves a complex interplay of genetic, immunological, and environmental factors.Genetic studies have identified several susceptibility loci, including HLA-Cw6 and IL23R, which are shared with psoriasis. Additionally, the presence of certain alleles, such as HLA-B27, is associated with a more severe disease course and a higher likelihood of axial involvement.
Phase:
NA
Details
Lead Sponsor:
South Valley University
Treatments:
Coat Protein Complex I
Genetic Variation
Methotrexate